FR2845395B1 - Vecteurs adenoviraux recombinants et leurs applications - Google Patents

Vecteurs adenoviraux recombinants et leurs applications

Info

Publication number
FR2845395B1
FR2845395B1 FR0212472A FR0212472A FR2845395B1 FR 2845395 B1 FR2845395 B1 FR 2845395B1 FR 0212472 A FR0212472 A FR 0212472A FR 0212472 A FR0212472 A FR 0212472A FR 2845395 B1 FR2845395 B1 FR 2845395B1
Authority
FR
France
Prior art keywords
applications
adenoviral vectors
recombinant adenoviral
recombinant
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0212472A
Other languages
English (en)
Other versions
FR2845395A1 (fr
Inventor
Marc Eloit
Bernard Klonjkowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ECOLE NATIONALE VETERINAIRE D
Institut National de la Recherche Agronomique INRA
Original Assignee
ECOLE NATIONALE VETERINAIRE D
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0212472A priority Critical patent/FR2845395B1/fr
Application filed by ECOLE NATIONALE VETERINAIRE D, Institut National de la Recherche Agronomique INRA filed Critical ECOLE NATIONALE VETERINAIRE D
Priority to AU2003283504A priority patent/AU2003283504B2/en
Priority to CA002501633A priority patent/CA2501633A1/fr
Priority to EP03775478A priority patent/EP1549751A2/fr
Priority to JP2004542569A priority patent/JP4951204B2/ja
Priority to PCT/FR2003/002964 priority patent/WO2004033696A2/fr
Priority to US10/530,712 priority patent/US8119396B2/en
Publication of FR2845395A1 publication Critical patent/FR2845395A1/fr
Application granted granted Critical
Publication of FR2845395B1 publication Critical patent/FR2845395B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C12N2710/10352—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR0212472A 2002-10-08 2002-10-08 Vecteurs adenoviraux recombinants et leurs applications Expired - Fee Related FR2845395B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0212472A FR2845395B1 (fr) 2002-10-08 2002-10-08 Vecteurs adenoviraux recombinants et leurs applications
CA002501633A CA2501633A1 (fr) 2002-10-08 2003-10-08 Vecteurs adenoviraux recombinants et leurs applications
EP03775478A EP1549751A2 (fr) 2002-10-08 2003-10-08 Vecteurs adenoviraux recombinants et leurs applications
JP2004542569A JP4951204B2 (ja) 2002-10-08 2003-10-08 組換えアデノウイルスベクターとその応用
AU2003283504A AU2003283504B2 (en) 2002-10-08 2003-10-08 Recombinant adenoviral vectors and applications thereof
PCT/FR2003/002964 WO2004033696A2 (fr) 2002-10-08 2003-10-08 Vecteurs adenoviraux recombinants et leurs applications
US10/530,712 US8119396B2 (en) 2002-10-08 2003-10-08 Recombinant adenoviral vectors and applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0212472A FR2845395B1 (fr) 2002-10-08 2002-10-08 Vecteurs adenoviraux recombinants et leurs applications

Publications (2)

Publication Number Publication Date
FR2845395A1 FR2845395A1 (fr) 2004-04-09
FR2845395B1 true FR2845395B1 (fr) 2008-05-30

Family

ID=32011498

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0212472A Expired - Fee Related FR2845395B1 (fr) 2002-10-08 2002-10-08 Vecteurs adenoviraux recombinants et leurs applications

Country Status (7)

Country Link
US (1) US8119396B2 (fr)
EP (1) EP1549751A2 (fr)
JP (1) JP4951204B2 (fr)
AU (1) AU2003283504B2 (fr)
CA (1) CA2501633A1 (fr)
FR (1) FR2845395B1 (fr)
WO (1) WO2004033696A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9750801B2 (en) * 2014-02-28 2017-09-05 Janssen Vaccines & Prevention B.V. Replicating recombinant adenovirus vectors, compositions, and methods of use thereof
NZ751966A (en) 2016-09-20 2023-03-31 Boehringer Ingelheim Vetmedica Gmbh New promoters
TW201823467A (zh) 2016-09-20 2018-07-01 德商百靈佳殷格翰維美迪加股份有限公司 犬腺病毒載體
TWI817933B (zh) 2016-09-20 2023-10-11 德商百靈佳殷格翰維美迪加股份有限公司 新穎ehv插入位點orf70
WO2018054822A1 (fr) 2016-09-20 2018-03-29 Boehringer Ingelheim Vetmedica Gmbh Nouveau vaccin contre la grippe porcine
KR102601875B1 (ko) * 2020-03-25 2023-11-14 (주)큐리진 면역 회피성 항종양 아데노바이러스

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9001766D0 (en) * 1990-01-25 1990-03-28 Univ Court Of The University O Vaccines
FR2705361B1 (fr) * 1993-05-18 1995-08-04 Centre Nat Rech Scient Vecteurs viraux et utilisation en thérapie génique.
CA2394099A1 (fr) * 1999-12-07 2001-06-14 Genethon Iii Vecteurs d'adenovirus canin destines au transfert de genes dans des cellules ciblees

Also Published As

Publication number Publication date
CA2501633A1 (fr) 2004-04-22
AU2003283504A1 (en) 2004-05-04
WO2004033696A3 (fr) 2004-05-27
JP2006501835A (ja) 2006-01-19
JP4951204B2 (ja) 2012-06-13
AU2003283504B2 (en) 2009-06-04
FR2845395A1 (fr) 2004-04-09
US20060233756A1 (en) 2006-10-19
EP1549751A2 (fr) 2005-07-06
US8119396B2 (en) 2012-02-21
WO2004033696A2 (fr) 2004-04-22

Similar Documents

Publication Publication Date Title
DK1680443T3 (da) Stabiliserede alfa-helix-peptider og anvendelser heraf
AP2007003990A0 (en) Improved adenoviral vectors and uses thereof
DE60130586D1 (de) Speicherzelle
AU2003295502A8 (en) Adenoviral vector vaccine
DE60239828D1 (de) Ür
DE60326917D1 (de) Richtkoppler
DK1484347T3 (da) Harpikssammensætning og optiske elementer
IS7783A (is) Flóð og fjöru-ker
DE50210116D1 (de) Mram-anordnung
DK1490404T3 (da) Laktoferrin
FI20010922A (fi) Uusia vektoreita
DE60226986D1 (de) Mram bitleitungwortleitungsarchitektur
DE60233254D1 (de) Ionisches material
DE602004030942D1 (de) Rekombinanter mikroorganismus
ITMI20011020A0 (it) Stabilizzanti per pvc
NO20034432D0 (no) Interferon gamma polypeptidvarianter
FR2845395B1 (fr) Vecteurs adenoviraux recombinants et leurs applications
DE50103863D1 (de) Aufblasbares Zelt
FR2827292B1 (fr) Photoproteines mutees et leurs applications
DE60300950D1 (de) MRAM Architektur
EE200300483A (et) Uudsed ekspressioonivektorid ja nende rakendused
DE60330481D1 (de) Gelung
DE50303362D1 (de) Kraftaufnehmer
FI20021110A (fi) Rakennuselementtijärjestely
NO20032963L (no) Peptidforbindelser

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130628